Russell Investments »

Prelude Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $157 76 2.07
2024-06-30 $5.6k 1.5k 3.81

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Broadcom Common Stock (AVGO)
Unitedhealth Group Common Stock (UNH)
Tesla Common Stock (TSLA)
Eli Lilly And Company Common Stock (LLY)
Visa Common Stock (V)
Equinix Common Stock (EQIX)

View all positions for Russell Investments

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Boxer Capital Management
BlackRock
T. Rowe Price Associates
Vanguard Group
Jacobs Levy Equity Management
Renaissance Technologies
Massachusetts Financial Services
Acadian Asset Management
Millennium Management
Geode Capital Management
Marshall Wace
Morgan Stanley
Two Sigma Advisers

View all funds holding Prelude Therapeutics